The remarkable appeal of microneedle controlled-release systems has captivated both the
academic community and pharmaceutical industry due to their great potential for achieving …

Protein and peptide drugs are predominantly administered by injection to achieve high
bioavailability, but this greatly compromises patient compliance. Oral and transdermal drug …

Diabetes chronic wound is a severe and frequently occurring medical issue in patients with
diabetes that often leads to more serious complications. Microneedles (MNs) can be used …

Deep cutaneous fungal infection (DCFI) is difficult to be treated by the traditional topical
application due to low drug transdermal efficiency, poor fungicidal effect, and easy to …

Microneedles (MNs) are micron-sized protrusions attached to a range of devices that are
used in therapeutic delivery and diagnosis. Because MNs can be self-applied, are painless …

Psoriasis is a chronic, autoimmune, and non-communicable skin disease with a worldwide
prevalence rate of 2–3%, creating an economic burden on global health. Some significant …

Transdermal delivery provides numerous benefits over conventional routes of
administration. However, this strategy is generally limited to a few molecules with specific …

Blood glucose (BG) monitoring is critical for diabetes management. In recent years,
microneedle (MN)-based technology has attracted emerging attention in glucose sensing …

Abstract Microneedle Array Patches (MAPs) are an emerging dosage form that creates
transient micron-sized disruptions in the outermost physical skin barrier, the stratum …

Transdermal delivery of drugs offers an interesting alternative for the administration of
molecules that present certain troubles when delivered by the oral route. It can produce …